Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
We have previously described the inhibition of glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat promoter by products of the H-ras and v-mos oncogenes. We have studied the effects of conditional oncogenes on expression of glucocorticoid-dependent indicator genes. Expression of the glucocorticoid-dependent transcription of the tyrosine aminotransferase gene was monitored in FTO-2B rat hepatoma cells during Mr 21,000 protein (p21) H-ras induction. A strong transcriptional repression of the tyrosine aminotransferase gene followed p21 H-ras expression. The sequences in a glucocorticoid-dependent promoter which are responsible for the oncogene-mediated repression could be localized to the glucocorticoid response element; a construct in which a 15-base pair glucocorticoid response element was inserted 5' of the thymidine kinase promoter exhibited the oncogene-mediated repression of transcription. We observed a strong repression of glucocorticoid-dependent promoters and promoter constructs not only in the presence of p21 H-ras and p37 v-mos but also with p60 v-src. p57 v-myc, however, had no effect. Oncogene expression is not a sufficient prerequisite for an initial repression of glucocorticoid hormone-dependent gene transcription, since even in the presence of constitutively high levels of oncogene product a transient stimulation of glucocorticoid-dependent gene expression was found. Protein synthesis inhibition experiments revealed that no hormonally induced cellular protein is needed for the oncogene-mediated repression. It seemed reasonable that this phenomenon might reflect oncogene effects on the glucocorticoid receptor. We, therefore, made measurements of the glucocorticoid receptor protein. In the presence of glucocorticoid hormone the receptor translocated rapidly from the cytoplasm to the nucleus. In normal NIH 3T3 cells, after 24-h treatments the nuclear receptor levels had declined to about 50% of those determined at 2 h and in the presence of p21 H-ras they declined to 15%. The levels of cytoplasmic receptor were not affected by p21 H-ras expression.
Jaggi
R
R
Ludwig Institute for Cancer Research, Bern Branch, Inselspital, Switzerland.
Höck
W
W
Ziemiecki
A
A
Klemenz
R
R
Friis
R
R
Groner
B
B
D000818:Animals; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D005914:Globins / Q000235:genetics; D005938:Glucocorticoids / Q000494:pharmacology*; D006358:Hot Temperature; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000502:physiology*; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000032:analysis* / Q000502:physiology; D012091:Repetitive Sequences, Nucleic Acid; D013937:Thymidine Kinase / Q000235:genetics; D014158:Transcription, Genetic; D014444:Tyrosine Transaminase / Q000235:genetics
D005938:Glucocorticoids; D011518:Proto-Oncogene Proteins; D011965:Receptors, Glucocorticoid; D005914:Globins; D015500:Chloramphenicol O-Acetyltransferase; D014444:Tyrosine Transaminase; D013937:Thymidine Kinase